anthranilic acid has been researched along with Coma in 1 studies
anthranilic acid: RN given refers to parent cpd; structure in Negwer, 5th ed, #565
anthranilic acid : An aminobenzoic acid that is benzoic acid having a single amino substituent located at position 2. It is a metabolite produced in L-tryptophan-kynurenine pathway in the central nervous system.
Coma: A profound state of unconsciousness associated with depressed cerebral activity from which the individual cannot be aroused. Coma generally occurs when there is dysfunction or injury involving both cerebral hemispheres or the brain stem RETICULAR FORMATION.
Excerpt | Relevance | Reference |
---|---|---|
") or gavage administration of the KYN pathway blocking drug Ro 61-8048, both of which enter the brain from the circulatory system, affect the time to first convulsion and/or coma during HBO in a manner consistent with a modulatory role for seizure activity." | 3.70 | Evidence that kynurenine pathway metabolites mediate hyperbaric oxygen-induced convulsions. ( Amiridze, N; Brown, OR; Dale, WE; Dang, Y, 2000) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Dale, WE | 1 |
Dang, Y | 1 |
Amiridze, N | 1 |
Brown, OR | 1 |
1 other study available for anthranilic acid and Coma
Article | Year |
---|---|
Evidence that kynurenine pathway metabolites mediate hyperbaric oxygen-induced convulsions.
Topics: Animals; Coma; Enzyme Inhibitors; Hyperbaric Oxygenation; Kynurenine; Kynurenine 3-Monooxygenase; Ma | 2000 |